No Detail Found!

Molecular Diagnostics for Tuberculosis: Gene Xpert MTBC/RIF Assay for Rapid Detection of Mycobacterium Tuberculosis and Extensively Drug-Resistant Strains (XDR) At KP

Author(s)
Qazi Ikram Ullah Timer Gara Teaching hospital
Anisullah Bachelor of Science in Medical Laboratory Technology (BS MLT), CECOS University Peshawar,Pakistan
Laiba Ikram Qazi Khyber Medical College Peshawar, Pakistan
Tayyaba Ikram Qazi Khyber Medical College Peshawar, Pakistan
Muhammad Atif University of Malakand.,Pakistan
Tooba ikram Qazi University Peshawar,Pakistan
Jalal shehzad Khyber Medical College Peshawar, Pakistan
Abstract
Tuberculosis (TB) remains a main global health concern, with high rates of infection and death. Fast recognition of Mycobacterium tuberculosis (MTB) and rifampicin resistance is crucial to recover treatment results and control transmission. Out-of-date tests like AFB culture and smear microscopy have limits in speed and sensitivity. The GeneXpert MTB/RIF assay suggests rapid, accurate detection of MTB and rifampicin resistance within 90 minutes. With Pakistan facing a high load of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB, this study evaluates the diagnostic accuracy of GeneXpert in pulmonary TB.1. To determine the prevalence of TB, rifampicin resistance, and associated risk factors of Mycobacterium tuberculosis among pulmonary tuberculosis (PTB). 2. Identify potential extensively drug-resistant Tuberculosis (XDR-TB) cases, informing effective treatment strategies.This study was conducted following approval from the Head of the TB Department at Timergara Teaching Hospital, Dir Lower, Khyber Pakhtunkhwa. Data were collected from patients who attended the TB Department of the timergara teaching hospital between January 2023 and December 2024. Demographic information and clinical characteristics were recorded. Sputum samples were collected in accordance with WHO guidelines and tested using the GeneXpert system to detect Mycobacterium tuberculosis complex (MTBC) and rifampicin resistance (RR). For samples that tested positive for RR, further testing for extensively drug-resistant TB (XDR-TB) was carried out to assess drug sensitivity and resistance patterns. The results were shared with physicians to guide appropriate treatment decisions. The study, conducted at Timer Garas Teaching Hospital from January 2023 to December 2024 with 7,157 participants suspected of pulmonary tuberculosis (PTB), found that 692 individuals tested positive for Mycobacterium tuberculosis complex (MTBC). The majority of participants were male (60%), and all showed PTB symptoms. A strong association was observed between certain symptoms-such as chronic cough, sputum production, fatigue, and shortness of breath-and MTBC positivity, with 100% positivity seen in those with sputum, fatigue, and breathlessness. Drug resistance testing among the 692 MTBC-positive cases revealed rifampicin resistance in 36 cases. Further extended drug resistance (XDR) analysis showed the highest resistance to Isoniazid (10 cases) and Fluoroquinolones (9), while Capreomycin and Ethionamide remained fully effective. Chi-square analysis showed statistically significant associations (p < 0.05) between MTBC and risk factors, including HIV (3.0%), tobacco use (5.0%), close contact with TB patients, and diabetes (6.5%). Erythrocyte sedimentation rate (ESR) levels were also elevated in MTBC-positive patients, indicating active inflammation. This study investigated 7,157 PTB-suspected patients, revealing strong relations between MTBC detection and signs like sputum production, fatigue, and shortness of breath, each showing 100% positivity. Of the 692 MTBC-positive cases, 36 were rifampicin-resistant, with supplementary resistance to isoniazid and fluoroquinolones. Momentous links were also found between MTBC and risk facters such as HIV, diabetes, tobacco use, and close contact people with TB patients. The results highlight the need for symptom-based screening, drug resistance monitoring, and joined care for at-risk groups. 
Publication Details
Page(s) 565-575
Published Journal: Pakistan Journal of Life and Social Sciences, Volume: 23, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
MTBC Gene Expert MDR WHO TB HIV ESR XDR PTB
References
Luetkemeyer A.F. .2016 .Evaluation of Xpert MTB/RIF versus AFB smear and culture to identify pulmonary tuberculosis in patients with suspected tuberculosis from low and higher prevalence settings. Clinical Infectious Diseases, 62(9) : 1081-1088.
Walusimbi S. .2013 .Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis. BMC infectious diseases, 13(1) : 507.
Lawn M.P.,Nicol M.P. .2011 .Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future microbiology, 6(9) : 1067-1082.
Marlowe E.M. .2011 .Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. Journal of clinical microbiology, 49(4) : 1621-1623.
.2011 .Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational “Howto”; practical considerations. , : .
Hillemann D. .2011 .Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. Journal of clinical microbiology, 49(4) : 1202-1205.
Blakemore R. .2010 .Evaluation of the analytical performance of the Xpert MTB/RIF assay. Journal of clinical microbiology, 48(7) : 2495-2501.
Maynard-Smith L. .2014 .Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review. BMC infectious diseases, 14(1) : 709.
Sharma S.K. .2015 .Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis. PloS one, 10(10) : e0141011.
Sofyanita E.N. .2021 .Correlation Of Erythrocyte Sedimentation Rate (ESR) and Lymphocyte Counts in Pulmonary Tuberculosis Patients during Intensive Treatment in Purwokerto City: Hubungan Nilai Laju Endap Darah (LED) dengan Jumlah Limfosit pada Pasien Tuberkulosis Paru Masa Pengobatan Tahap Intensif di Kota Purwokerto. Borneo Journal of Medical Laboratory Technology, 4(1) : 249-254.
Organization W.H. . .: 2010 global report on surveillance and response, in Multidrug and extensively drug-resistant TB (M/XDR. 2010, : 71-71.
Zhao Y. .2012 .National survey of drug-resistant tuberculosis in China. New England Journal of Medicine, 366(23) : 2161-2170.
Tuberculosis N.T.S.G.o.t.E.S.S.f. .2012 .The prevalence of pulmonary tuberculosis in a national survey across China in 2010. Zhonghua Jie He He Hu Xi Za Zhi. Implementing Office of the Epidemiological Sampling Survey for Tuberculosis, 35(9) : 665-658.
Li X. .2012 .Population-based surveillance of extensively drug- resistant tuberculosis in Shandong Province, China. International journal of tuberculosis and lung disease, 16(5) : 612-614.
Jacobson K.R. .2010 .Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis. Clinical infectious diseases, 51(1) : 6-14.
Heritage A. . .The American heritage medical dictionary. 2008: Houghton Mifflin Harcourt., : .
Raheem A.H. .2025 .Erythrocyte sedimentation rate in patients with positive sputum for AFB and negative HIV serological test. Muthanna Medical Journal, 3(1) : 17-23.
Yayan J. .2024 .Early detection of tuberculosis: a systematic review. Pneumonia, 16(1) : 11.
Opota O. .2016 .Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country. Clinical microbiology and infection, 22(7) : 613-619.
Chang K. .2012 .Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. Journal of Infection, 64(6) : 580-588.
Nugussie D.A.,Mohammed G.A.,Tefera A.T. .2017 .Prevalence of Smear‐Positive Tuberculosis among Patients Who Visited Saint Paul's Specialized Hospital in Addis Ababa, Ethiopia. , : 6325484.
Tulu B. .2014 .Smear positive pulmonary tuberculosis and its risk factors among tuberculosis suspect in South East Ethiopia; a hospital based cross-sectional study. BMC research notes, 7(1) : 285.
Ahmad T.,East J Sci Res T. .2015 .Prevalence of tuberculosis infection in general population of district Dir (lower) Pakistan. , 23(1) : 14-17.
Ahmad T. .2013 .Epidemiology of tuberculosis: current status in district Dir (lower) Pakistan. Int J Sci Eng Res, 4(11) : 755-63.
Chen Z. .2025 .a critical analysis of global and Chinese key data. Zoonoses, 5(1) : 999.
Ikuabe P.O. and I.D.,Ebuenyi P.O. and I.D. .2018 .Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria. The Pan African Medical Journal, 29 : 204.
Arega B.,Menbere F.,Getachew Y. .2019 .Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC infectious diseases, 19(1) : 307.
Ejeta E.,Xpert MTB .2018 .RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high human immunodeficiency virus setting in gambella regional state, southwest ethiopia. Journal of clinical tuberculosis and other Mycobacterial diseases, 12 : 14-20.
Semunigus T. .2016 .Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia. Annals of clinical microbiology and antimicrobials, 15(1) : 50.
Eliso M.,Belay M. .2015 .Prevalence of smear positive pulmonary tuberculosis among outpatients presenting with cough of any duration in Shashogo Woreda, Southern Ethiopia. BMC Public Health, 15(1) : 112.
Sinshaw W. .2019 .Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia. BMC infectious diseases, 19(1) : 641.
Organization W.H. .2020 .. World Health Organization Global Tuberculosis Report, 232 : .
Teweldemedhin M. .2018 .Tuberculosis-Human Immunodeficiency Virus (HIV) co-infection in Ethiopia: a systematic review and meta-analysis. BMC infectious diseases, 18(1) : 676.
Mesfin E.A. .2018 .Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PloS one, 13(6) : e0197737.
Restrepo B.I. .2018 .Diabetes and tuberculosis. Understanding the host immune response against mycobacterium tuberculosis infection. , : 1-21.
Marshall ,A.-M. .2020 .Smoking prevalence among tuberculosis patients: A crosssectional study in Bangladesh and Pakistan. Tobacco induced diseases, 18 : 70.
Narasimhan P. .2013 .Risk factors for tuberculosis. Pulmonary medicine, : 828939.
Etim N.G. .2024 .Risk factors of tuberculosis and strategies for prevention and control. Int J Innov Healthcare Res, 12(1) : 1-3.
Jaleta K.N. .2017 .Rifampicin-resistant Mycobacterium tuberculosis among tuberculosispresumptive. Infection and drug resistance, : 185-192.
Brigden M.L. .1999 .Clinical utility of the erythrocyte sedimentation rate. American family physician, 60(5) : 1443-1450.
Levay P.F.,Viljoen M. .2002 .Erythrocyte sedimentation rates equal to or above 100 mm/h in the preAIDS era. , : .
Al-Marri M.,Kirkpatrick M. .2000 .Erythrocyte sedimentation rate in childhood tuberculosis: is it still worthwhile?. The International Journal of Tuberculosis and Lung disease, 4(3) : 237-239.
Sarkar K. .2013 .Erythrocyte sedimentation rate may be an indicator for screening of tuberculosis patients for underlying HIV infection, particularly in resource-poor settings: an experience from India. , : .
0

Citations

0

Downloads

76

Views